Agenda
-
2:00 PM-3:30 PM EST In-Person Meeting Room
Pre-Conference: Early Career Committee Workshops - Non-CME
-
-
5:30 PM-6:00 PM EST In-Person Ballroom
Challenges in implementing methylation in screening and diagnostics
-
9:00 AM-9:10 AM EST In-Person Ballroom
Acknowledgement to Country and Introduction by the Farrah Fawcett Foundation
-
9:10 AM-9:30 AM EST In-Person Ballroom
Farrah Fawcett Foundation Keynote Address: Update on the ACT Study
Speakers:
Dr Duncan Charles Gilbert, MRCP FRCR PhD
Consultant Clinical Oncologist and Associate Professor in Cancer and Clinical TrialsUniversity Hospitals Sussex NHS Foundation Trust, and University College London
-
9:30 AM-9:45 AM EST In-Person Ballroom
ASCRS Update: Screening and Management of Anal Dysplasia and Squamous Cell Carcinoma
-
9:45 AM-10:00 AM EST In-Person Ballroom
The Evolving Landscape of HPV Disease: Mechanisms, Immune Evasion, and Therapeutic Vaccines
-
10:00 AM-10:15 AM EST In-Person Ballroom
Update on the expanding role of chemotherapy in the treatment of anal cancer
-
10:20 AM-10:40 AM EST In-Person Ballroom
Oncology Updates - What we're preventing - Selected Oral Abstract Presentations - Non-CME
-
11:25 AM-11:40 AM EST In-Person Ballroom
The role of pelvic physiotherapy in the management of anal cancer
-
12:10 PM-12:30 PM EST In-Person Ballroom
Optimising the patient experience - a team approach - Selected Oral Abstract Presentations - Non-CME
-
1:55 PM-2:20 PM EST In-Person Ballroom
Biomarkers to improve efficiency and coverage of anal cancer prevention programs
-
2:20 PM-3:00 PM EST In-Person Ballroom
Update on Epidemiology - Selected Oral Abstract Presentations - Non-CME
-
3:30 PM-4:00 PM EST In-Person Ballroom
Successes and challenges that might influence the roll out of anal screening programs
Speakers:
Professor Karen Veronica Canfell AC, D.Phil
Professor of Public Health & NHMRC Leadership Fellow; Lead - Cancer Elimination Collaboration; Lead - Elimination Partnership In Cervical Cancer (EPICC)Cancer Elimination Collaboration (CEC), Sydney School of Public Health, University of Sydney
-
4:20 PM-5:00 PM EST In-Person Ballroom
Screening Options - Selected Oral Abstract Presentations - Non-CME
-
6:30 PM-9:30 PM EST In-Person Imperial Hotel, Erskineville
Optional Social Activity - Drag and Dine
For more information click on IANS Social Activites
-
9:00 AM-10:30 AM EST In-Person Ballroom
Acknowledgment to Country & Different Perspectives on Screening Panel
Panelist:
- Elizabeth Stier, MD, Professor, Boston University Chobanian and Avedisian School of Medicine
- Mary Poynten, MBBS, MPH, PHD, Senior Research Fellow, Kirby Institute, UNSW Sydney
- David Chromy, MD PhD, Medical University of Vienna
- Dr. Carlos Manuel Angeles San Mateo, MD, MA, FACS, DABS, DipABLM, FASCRS, Colorectal Surgeon, Alkimiya Surgical Systems, PC
- Long Sui, Medical Practitioner Qualification Certificate;Medical Practitioner License, Chief Physician, Professor, Obstetrics and Gynecology Hospital,Fudan University
- Naokatsu Ando, MD, PhD, Head of HIV outpatient clinic, Japan Institute for Health Security
-
12:00 PM-1:00 PM EST In-Person Ballroom
Screening & guidelines high-risk groups - Selected Oral Abstract Presentations - Non-CME
-
2:00 PM-2:20 PM EST In-Person Ballroom
Standardising Clinical Trial Design - definitions, AE collection, cure vs. clearance
-
Speakers:
Dr Duncan Charles Gilbert, MRCP FRCR PhD
Consultant Clinical Oncologist and Associate Professor in Cancer and Clinical TrialsUniversity Hospitals Sussex NHS Foundation Trust, and University College London
-
3:45 PM-5:00 PM EST In-Person Ballroom
Implementation - Selected Oral Abstract Presentations - Non-CME
-
6:30 PM-11:30 PM EST In-Person Watersedge
Optional Social Activity - Watersedge Dinner
For more information click on IANS Social Activites
-
Speakers:
John Michael Berry-Lawhorn, MD
Retired Clinical Professor of Medicine and Attending PhysicianUCSF and Farabi Wellness Center
-
Panelist:
- Tamzin Cuming, MD, IANS President, IANS
- David Chromy, MD PhD, Medical University of Vienna
- Sally Barbara Murray, FAChSHM, FAFPHM, MHScPHP, MPHTM, MBBS, Sexual Health Physician, Fremantle/Fiona Stanley Hospital/Royal Perth Hospital
- Gary Clifford, PhD
-
Speakers:
Dr Jennifer Margaret Roberts, MBBS FRCPA
Pathologist, Senior Research FellowKirby Institute
-
11:40 AM-11:55 AM EST In-Person Ballroom
The role of HPV DNA in determining follow-up of anal dysplasia
Speakers:
Dr Benjamin Hugh Armstrong, BBiomedSc MBBS MPH FRCPA MAIMS MASM
Director of MicrobiologyDouglass Hanly Moir Pathology
-
11:55 AM-12:30 PM EST In-Person Ballroom
Treatments, screening diagnostics, and AI - Selected Oral Abstract Presentations - Non-CME
-
1:30 PM-2:30 PM EST In-Person Ballroom
Panel - Learning from patient experience - using patients' perspectives to shape expectations and guide future research - Non-CME
-
-
3:15 PM-3:30 PM EST
Women without other known risk factors
-
3:30 PM-3:45 PM EST In-Person Ballroom
Canada's first dedicated cancer clinic for trans and non-binary individuals
